Randomised controlled trial and cost-effectiveness evaluation of an interactive video system to promote shared decision making in general practice

ISRCTN ISRCTN37846533
DOI https://doi.org/10.1186/ISRCTN37846533
Protocol serial number PSI04-13
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Funder NHS Primary and Secondary Care Interface National Research and Development Programme (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
24/08/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Elizabeth Murray
Scientific

Primary Care and Population Sciences
University College London
Holborn Union Building
Archway Campus
London
N19 3EU
United Kingdom

Phone +44 (0)20 7288 3091
Email elizabeth.murray@pcps.ucl.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesTo determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUrological and genital diseases: Other urological and genital disease
InterventionPatients with clinical diagnosis of benign prostatic hypertrophy were referred into the study by their General Practitioner (GP). The intervention group received an information package consisting of a session with an evidence based interactive video disc plus printout plus booklet; the control group received normal care only. Data were collected at baseline, three months and nine months.
Intervention typeOther
Primary outcome measure(s)

Patients' and general practitioners' perceptions of who made the decision, decisional conflict scores, treatment choice and prostatectomy rate, American Urological Association symptom scale, costs, anxiety, utility, and general health status.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/1999

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration112
Key inclusion criteria1. Men attending participating general practices with a clinical diagnosis of benign prostatic hypertrophy and sufficient command of English to consult without an interpreter
2. Any clinical suggestion of carcinoma of the prostate
3. Chronic retention of urine
4. Recent urinary tract infection
5. Recent acute urinary retention
6. History of prostate surgery
7. Severe visual or hearing impairment, such that the patient could not use the decision aid
8. Severe learning difficulties or mental illness, such that the patient might not be competent to reach an informed decision
Key exclusion criteria1. Any clinical suggestion of carcinoma of the prostate
2. Chronic retention of urine
3. Recent urinary tract infection
4. Recent acute urinary retention
5. History of prostate surgery
6. Severe visual or hearing impairment, such that the patient could not use the decision aid
7. Severe learning difficulties or mental illness, such that the patient might not be competent to reach an informed decision
Date of first enrolment01/01/1996
Date of final enrolment31/12/1999

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Primary Care and Population Sciences
London
N19 3EU
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 01/09/2001 Yes No